Free Lesson Preview
This is just the beginning
The full CRC track covers 8 courses from study start-up to close-out β the skills sponsors actually look for.
View enrollment optionsAlready enrolled? Sign in
Clinical Research Coordinator
Full course Β· Study Start-Up and Site Activation
Free Lesson Preview
The full CRC track covers 8 courses from study start-up to close-out β the skills sponsors actually look for.
View enrollment optionsAlready enrolled? Sign in
Execute a comprehensive final activation checklist verifying every regulatory, operational, and logistical requirement before first enrollment.
The notification arrives at 7:42 AM on a Wednesday. The subject line reads: "Site Activation Letter -- Study [Protocol Number]." The coordinator opens it, scans the attached PDF, and feels a wave of accomplishment. Weeks of feasibility work, regulatory submissions, essential record collection, the SIV itself, and the relentless post-SIV follow-up have led to this moment. The sponsor has formally authorized the site to begin enrolling participants.
And then the coordinator looks at the pharmacy. The investigational product is on the shelf--received, verified, temperature-logged. But the research pharmacist completed IVRS training in the test environment and never confirmed live-mode access. The EDC system shows "active" for all users, but the coordinator has not actually logged in and navigated to the data entry screens since credentials were provisioned. The safety reporting pathway? It was discussed at the SIV, the after-hours contact numbers are posted in the binder, but no one has tested whether the sponsor's safety reporting portal accepts submissions from the site's network.
The activation letter is permission. It is not readiness. And the distance between those two things--between authorization on paper and operational capacity in practice--is where the final activation checklist lives.
I have seen sites receive activation and attempt to screen their first participant the same afternoon, only to discover mid-visit that the IVRS will not randomize because the site's pharmacy account was never switched from training mode to live mode. I have watched coordinators scramble to enter screening data into an EDC system they cannot access because the browser configuration at the workstation in the clinic is different from the one on the coordinator's office laptop. These are not catastrophic failures. They are embarrassments--and they are entirely preventable.
This lesson is about the final verification that bridges the sponsor's activation letter to actual enrollment readiness. Not the action item tracker from the previous lesson, which managed the post-SIV work. This is the go/no-go checklist: a systematic confirmation, conducted after all action items are resolved and the activation letter is in hand, that every system works, every pathway is open, and every person who needs to do something on enrollment day can actually do it.
What you will learn4 objectives
By the end of this lesson, you will be able to:
Progress saves itself β finish reading and this lesson completes